Compare Corning Incorporated (GLW) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Corning Incorporated vs Tenet Healthcare Corporation — how do they compare? Corning Incorporated trades at $157.25 (market cap $140.62B), while Tenet Healthcare Corporation trades at $260 (market cap $20.92B). The key difference: Corning Incorporated is far larger — about 6.7× Tenet Healthcare Corporation's market cap, and Corning Incorporated pays a 0.69% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Corning Incorporated for 35 Days and Tenet Healthcare Corporation for 15 Days on average.
| GLW | THC | |
|---|---|---|
Market Cap | $140.62B | $20.92B |
Volume | 5,163,560 | 455,764 |
Sector | Technology | Health |
52-Week High | $255.79 | $280.77 |
52-Week Low | $78.03 | $161.37 |
Typical Hold Time | 35 Days | 15 Days |
Enterprise Value | $147.50B | $32.00B |
Dividend Yield | 0.69% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Corning (GLW) trades at $163.21, down 3.41% today, but maintains a bullish technical outlook with strong support at $160. The company recently secured a significant $3 billion fiber supply agreement with AT&T, boosting growth prospects in the AI infrastructure sector. Despite elevated valuation ratios (P/E 75.23), GLW has consistently beaten earnings estimates in recent quarters, with Q3 2026 EPS expected at $0.878. Operating cash flow improved to $2.7 billion in 2025, supporting the company's dividend payments and strategic investments.
GLW presents a compelling growth story driven by AI infrastructure demand, with analyst consensus favoring Buy ratings (56.75%) and a $171.25 price target offering 5% upside. Key risks include patent litigation concerns and the stock's premium valuation requiring sustained earnings growth. The AT&T partnership positions Corning to capitalize on expanding fiber optic needs, though investors should monitor competitive pressures and execution risks in the rapidly evolving technology sector.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Corning Incorporated
Corning Inc is a leader in materials science, specializing in the production of glass, ceramics and optical fiber. The firm supplies its products for a wide range of applications, from flat-panel displays in televisions to gasoline particulate filters in automobiles to optical fiber for broadband access, with a leading share in many of its end markets.
Read more on GLW →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
